Compound index

Small-Molecule Drugs

Metformin

FDA-approved for specific indicationsFDA-approved

Last reviewed: 2026-11-19

Evidence status & limitations

Diabetes evidence does not establish efficacy for longevity in people without diabetes.

Regulatory status

FDA approval applies only to the named products and indications below. It does not approve every formulation or other use.

  • Glucophage · Type 2 Diabetes

    Glycemic control in type 2 diabetes; age eligibility depends on the labeled product.

    Authoritative label record

Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.

WADA prohibited status: current list and context

Known risks & open questions

Gastrointestinal effects, vitamin B12 reduction and rare lactic acidosis in susceptible settings are documented concerns.

Key sources

Indication-specific regulatory sources and editorial screen checked November 19, 2026. This is not an exhaustive systematic review; consult current labels.

Related compounds

  • Apomorphine

    Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications

  • Finasteride

    Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications

  • Methylthioninium chloride

    Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications

  • Minoxidil

    Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications

  • Omeprazole

    Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications

Related glossary terms